欧美午夜艳片欧美精品|裸身美女无遮挡永久免费视频|红杏视频网址|欢乐合租屋赵猛TXT|19岁RAPPER潮水大豆行情|无遮挡粉嫩小泬久久久久|手指凹缝隙挖水视频

×

NHU Holding Group Ranks Among Top 500 in Both R&D Investment and Invention Patents for 2025

Time:2025-10-09

Recently, the All-China Federation of Industry and Commerce released the “Top 500 Private Enterprises by Invention Patents 2025” and “Top 500 Private Enterprises by R&D Investment 2025”. NHU Holding Group once again earned a place on both prestigious lists.

Our robust R&D capabilities and solid patent portfolio have secured our continued recognition, highlighting our innovative vitality and strong growth momentum within the industry. This dual achievement reflects our long-term dedication to our core business, our steadfast focus on industrial development, and our active alignment with national strategies. It also reaffirms our pioneering spirit and unwavering commitment to technological innovation and intellectual property protection.

For more than three decades, NHU has been deeply engaged in fine chemicals, pharmaceuticals, equipment, and education, continuously strengthening the innovation, industrial, and value chains. Each year, we invest heavily in cutting-edge technology research and product development. Over the past five years, we have invested 5.506 billion yuan in R&D, averaging over 5% of our annual sales revenue.

In fine chemicals, NHU has achieved breakthroughs in key technologies that have long constrained the development of vitamin E, vitamin A, PPS, and methionine. In pharmaceuticals, we have established strong product portfolios in cardiovascular and diabetes therapeutics, while advancing research into innovative small nucleic acid drugs.

By the end of 2024, NHU held 1,020 valid domestic patents and 129 valid international patents. In addition, research outcomes from our university collaborations have received one China Patent Gold Award and one Silver Award, reinforcing our commitment to building a solid foundation for sustainable development.

Back To List

Learn more